Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
85 hedge funds and large institutions have $166M invested in Immunomedics Inc in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 14 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 16
17% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $12.9M
9% more capital invested
Capital invested by funds: $153M → $166M (+$13.1M)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
1% less funds holding
Funds holding: 86 → 85 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$2.45M |
| 2 |
Millennium Management
New York
|
+$1.4M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$893K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$772K |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$422K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.92M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$849K |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$797K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$528K |
| 5 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
-$409K |
IMMU Hedge Fund Activity: Q2 2015 in Review
85 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2015, worth a combined $166M — up 8.6% from $153M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of IMMU and 13 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 36 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.45M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $1.92M sold.
- 85 institutional investors held Immunomedics Inc (IMMU) as of Q2 2015, down from 86 in Q1 2015.
- Funds reported $166M of Immunomedics Inc stock for Q2 2015, up 8.6% quarter-over-quarter.
- 13 funds opened new Immunomedics Inc positions in Q2 2015 and 14 closed out, a net change of -1 holder.
- The largest Immunomedics Inc buyer in Q2 2015 was Perceptive Advisors, an estimated $2.45M added.
- The largest Immunomedics Inc seller in Q2 2015 was Tekla Capital Management, an estimated $1.92M sold.
Based on aggregated 13F filings for Q2 2015.